Study Stopped
no funds for TSH testing
Thyroid Profiles in Patients With Acute Illness
Thyroid Profiles in Middle Eastern Patients Admitted With Acute Illness: Prevalence, Clinical Features and Impact on Mortality
1 other identifier
observational
N/A
1 country
1
Brief Summary
Patients admitted to the hospital with acute illness may have a wide spectrum of thyroid function abnormalities. It is largely unknown whether such aberrations are temporary or persist for a long time, and whether they impact prognosis of such patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 20, 2023
CompletedFirst Posted
Study publicly available on registry
August 8, 2023
CompletedStudy Start
First participant enrolled
October 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2025
CompletedFebruary 25, 2025
February 1, 2025
1.3 years
July 20, 2023
February 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
In hospital mortality
All-cause death rate in patients with abnormal thyroid function compared with death in those with no abnormal thyroid function during the patients hospital stay..
From time of study entry until the date of death from any cause, assessed up to 2 weeks.
Secondary Outcomes (1)
6-month mortality rate
From date of study entry until the date of death from any cause, assessed up to two weeks.
Study Arms (2)
GROUP 1: Acute illness and abnormal thyroid function
Patients admitted to the hospital with acute illness and found to have thyroid function abnormalities.
GROUP 2: Acute illness and normal thyroid function
Patients admitted to the hospital with acute illness and found to have normal thyroid function.
Interventions
Blood test as above
Eligibility Criteria
nclusion Criteria: All patients admitted to the hospital with acute illness will have their serum level of thyroid stimulating hormone and free T4 and T3 measured on admission. Clinical and laboratory profiles of patients with abnormal thyroid function (Group 1) will be compared to those with normal thyroid function (Group 2). Serum thyroid test will be repeated at 6 months. Short and long term survival of both groups will be compared as well. Diagnosis on admission is acute illness includes: heart failure, acute coronary syndrome, sepsis, acute stroke, hypotension, acute system-organ failure including renal and hepatic failure.
You may qualify if:
- Hospital admission
- Adults aged 18 years and above
- Willing to sign an informed consent
- Diagnosis on admission is acute illness that includes: heart failure, acute coronary syndrome, sepsis, acute stroke, hypotension, acute system-organ failure including renal and hepatic failure.
You may not qualify if:
- Age less than 18 years.
- Refusal to sign consent.
- Admission for a reason not classified as acute illness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istishari Hospital
Amman, 11888, Jordan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 20, 2023
First Posted
August 8, 2023
Study Start
October 15, 2023
Primary Completion
January 15, 2025
Study Completion
January 30, 2025
Last Updated
February 25, 2025
Record last verified: 2025-02